Clinical Trial
Dose-finding study of candesartan cilexetil plus hydrochlorothiazide in patients with mild to moderate hypertension
Affiliations
- PMID: 9331013
Item in Clipboard
Clinical Trial
Dose-finding study of candesartan cilexetil plus hydrochlorothiazide in patients with mild to moderate hypertension
J Hum Hypertens.
1997 Sep.
No abstract available
Similar articles
-
Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension.Drugs. 2002;62(5):787-816. doi: 10.2165/00003495-200262050-00006. Drugs. 2002. PMID: 11929332 Review.
-
Combination therapy with candesartan cilexetil plus hydrochlorothiazide in patients unresponsive to low-dose hydrochlorothiazide.J Hum Hypertens. 1997 Sep;11 Suppl 2:S65-6. J Hum Hypertens. 1997. PMID: 9331012 Clinical Trial. No abstract available.
-
Effects of candesartan cilexetil in patients with severe systemic hypertension. Candesartan Cilexetil Study Investigators.Am J Cardiol. 1999 Aug 1;84(3):289-93. doi: 10.1016/s0002-9149(99)00278-7. Am J Cardiol. 1999. PMID: 10496437 Clinical Trial.
-
Efficacy and tolerability of a combination tablet of candesartan cilexetil and hydrochlorothiazide in insufficiently controlled primary hypertension--comparison with a combination of losartan and hydrochlorothiazide.Blood Press. 2000;9(4):214-20. doi: 10.1080/080370500439100. Blood Press. 2000. PMID: 11055474 Clinical Trial.
-
Candesartan plus hydrochlorothiazide: an overview of its use and efficacy.Expert Opin Pharmacother. 2012 Dec;13(18):2699-709. doi: 10.1517/14656566.2012.745511. Epub 2012 Nov 21. Expert Opin Pharmacother. 2012. PMID: 23170938 Review.
Cited by
-
Blood pressure-lowering efficacy of monotherapy with thiazide diuretics for primary hypertension.Cochrane Database Syst Rev. 2014 May 29;2014(5):CD003824. doi: 10.1002/14651858.CD003824.pub2. Cochrane Database Syst Rev. 2014. PMID: 24869750 Free PMC article.
-
Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T).Vasc Health Risk Manag. 2011;7:85-95. doi: 10.2147/VHRM.S17004. Epub 2011 Feb 17. Vasc Health Risk Manag. 2011. PMID: 21415922 Free PMC article.
-
Candesartan cilexetil. A review of its use in essential hypertension.Drugs. 1998 Nov;56(5):847-69. doi: 10.2165/00003495-199856050-00013. Drugs. 1998. PMID: 9829158 Review.
-
Candesartan cilexetil: a pharmacoeconomic review of its use in chronic heart failure and hypertension.Pharmacoeconomics. 2006;24(12):1249-72. doi: 10.2165/00019053-200624120-00008. Pharmacoeconomics. 2006. PMID: 17129078 Review.
-
Candesartan cilexetil plus hydrochlorothiazide combination: a review of its use in hypertension.Drugs. 2002;62(5):787-816. doi: 10.2165/00003495-200262050-00006. Drugs. 2002. PMID: 11929332 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical